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Summary
The United Kingdom is a science superpower. In terms of both quality and productivity, 
our research base punches above its weight’, setting a worldwide benchmark for excellence.
Government spending on the science base has been protected since 2010, with a flat-cash- 
ring-fenced budget for annual ‘resource’ spending distributed by the research councils, the 
Higher Education Funding Council and others. Annual ‘capital’ budgets have varied. The 
Government has already announced that capital spending within the science budget will 
be protected — in real terms — up to the end of 2021. The Government’s Spending Review 
on 25 November will determine the science — and innovation — budget allocations for 
the rest of this Parliament. 
The UK has fallen behind its competitors in terms of total R&D investment and this will 
put UK competitiveness, productivity and high-value jobs at risk if it is not reversed. The 
Government should produce a long term ‘roadmap’ for increasing public and private 
sector science R&D investment in the UK to 3% of GDP — the EU target. This would 
send an important signal about the long term stability and sustainability of our science 
and innovation ecosystem, supercharging private sector R&D investment from industry, 
charities and overseas investors alike.
A more robust system is needed to integrate capital and resource funding allocations. 
The Government should urgently review existing capital allocations to ensure sufficient 
resource is in place to fully ‘sweat our assets’. Sufficient resource funding will only 
materialise, however, with an upward trajectory in the resource budget. 
The Spending Review is being conducted under present accounting protocols, dealing with 
capital and resource budgets for science separately. ‘ESA-10’ accounting rules will in future 
count resource expenditure on R&D as capital, reflecting the fact that all expenditure 
on science research is an investment — an asset — in future economic capacity. The 
Government in the Spending Review should make it clear that this rules revision will not 
be used as a means to change the underlying funding settlement. 
The ‘dual support’ system has produced a world class and highly efficient system for 
scientific research. Any significant changes to this system, including the balance of 
funding between research councils and university funding councils, would require a clear 
justification, which has yet to emerge. The Government should make clear its continued 
commitment to the dual support system, and the previous Government’s 2010 iteration 
of the Haldane Principle in the forthcoming Spending Review. A significant element of 
research funding should continue to be channelled though both the research councils and 
the higher education funding authorities. Clear justification will also be needed for any 
significant change in funding allocations between the research councils, and we caution 
against a radical reorganisation which could potentially harm the research programme. 
Any expansion of the innovation catapult network should not come at the expense 
of other innovation priorities. The Government should focus on consolidating the 
existing catapults, to ensure that all will have the necessary operating resource 
and business strategies to operate at peak capacity. To show a clear commitment to 
innovation more generally, the Government should ring-fence Innovate UK’s budget. 
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The Government should also retain the current system of innovation grants — rather 
than loans — as a key policy tool, alongside R&D tax credits, for de-risking innovation 
investment. 
The Spending Review will have a profound impact on our science base and our future 
prosperity. We have to get it right. We have a duty to take care that our spending and 
structural decisions in this area do more than merely maintain the status quo. If we get 
our spending priorities, our policies, regulatory frameworks or our immigration policy 
wrong, we will be on the wrong side of history. The Government must ensure that the UK 
remains a scientific superpower.
5 The science budget 
1 Introduction
The case for science and innovation
1. The United Kingdom is a science superpower. In terms of both quality and 
productivity, our research base “punches above its weight”,1 setting a worldwide benchmark 
for excellence. Numerous witnesses in our inquiry provided evidence of this, including 
Innovate UK:
The strength of our globally respected research base is an unparalleled strategic 
asset for the UK and we must continue to invest in it. With 0.9% of the world’s 
population, and 3.2% of its R&D spend, we produce 15.9% of its most important 
research output. The UK is home to 4 of the top 6 Universities in the world. 
The output of this engine of new knowledge discovery is a constant source of 
potential commercial advantage.2
2. The UK has much to boast about. UK research is cited in 10.9% of all patent 
applications worldwide, we rank 2nd globally for the quality of our scientific research 
institutions, we come 2nd in the Global Innovation Index (which compares 143 countries 
on 81 indicators) and are 4th for university-industry collaboration.3 
3. This is an excellence driven science and innovation ecosystem that has produced 80 
Nobel Prize winners but also some extraordinary improvements in our way of life, as the 
Campaign for Science and Engineering illustrated:
• Global research efforts have led to cancer treatments and interventions delivering 
health gains equivalent to £124 billion for UK patients between 1991 and 2010 through 
prevention, early identification, and improved survival. 
• One million more properties were protected in the floods of 2013–14 compared to 
similar floods in 2007 as a result of government-funded research. This saved £2.6 
billion of lost working days in London alone and £2 billion in fewer and less expensive 
insurance pay- outs. 
• R&D has improved aircraft fuel efficiency by 30% since 1990, saving over 400 million 
tonnes of CO2 per year, and is expected to improve efficiency by a further 38% between 
2010 and 2050.4  
4. It is important to remember that these achievements rest on a long established 
principle, recognised by successive governments, that excellent research, translated into 
innovation, not only brings huge societal benefits — widespread electrification, better 
healthcare, mass production of food, better transport links — but is also a precondition 
for productivity growth. Indeed the Government’s Productivity Plan opens its chapter on 
Science with the following:
1 Universities UK (TSB0045)
2 Innovate UK (TSB0048), para 7
3 Royal Society, Building a Stronger Future (Feb 2015)
4 Campaign for Science and Engineering (TSB0051), para  7
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The creation and application of new ideas is critical for long-run productivity 
growth. There is clear and robust evidence of a link between R&D spending 
and national productivity.5
In our increasingly knowledge-based economy, the pursuit of excellence in research and 
innovation breeds competitiveness and high-value jobs growth, and UK researchers play 
a critical role in addressing major national and global challenges.
5. It is notable that even in difficult financial times this is an argument the public ‘get’. 
A BIS/Ipsos Mori Public Attitudes to Science survey in 2014 showed that 76% thought that 
scientific research made a direct contribution to economic growth, 79% agreed that even 
if it brought no immediate benefits scientific research that advances knowledge should 
be funded by the Government, and that 65% disagreed that such funding should be cut 
because it might be better spent elsewhere.6 
6. If the economic and social case for investing in science has been won with both 
government and the public, our science and innovation ecosystem should be fully invested 
and operating at peak capacity. The Chancellor has certainly been a consistent champion 
for science, protecting the science ring-fence in cash terms throughout the last Parliament 
and reversing damaging cuts to capital spending at a time of significant cuts to other areas 
of government spending. Nevertheless, the instability in capital spending and the real 
terms loss in spending power has had its consequences, as we discuss below.
7. Furthermore, while our excellence in research is world leading and unquestioned, 
numerous witnesses made the case that our success in exploiting this research, though 
improving, remains suboptimal. The Centre for Process Innovation Limited, a founder 
partner of the High Value Manufacturing Catapult, working at the intersection of 
university-industry collaboration, concluded that although the catapult network and 
Technology Transfer Offices are beginning to make a difference: “most UK universities 
[still] have limited ability to convert research findings into commercial products and 
services”.7 The Institution of Engineering and Technology was emphatic about the need 
for improvement in commercialisation support, currently funded through the innovation 
budget:
The UK has consistently failed to exploit fully the results of its research outputs. 
There are many reasons for this including short-termism, risk aversion and an 
academic bias against industry and commerce. This is against a backdrop of 
rapid technical advances and industrial expansion in Asia and elsewhere and 
thus solving the issue is becoming increasingly urgent.8 
8. The Government will make a decision on science and innovation funding as part of 
its Spending Review, to be published on 25 November. Simultaneously, the findings of the 
Dowling Report into strengthening university-industry collaborations, the Nurse Review 
into the structure of the Research Councils and the McKinsey Review into the structure 
of the Department for Business, Innovation and Skills are also being considered and 
will inevitably shape decisions about spending allocations. As these decisions are taken 
5 HM Treasury, Fixing the foundations: Creating a more prosperous nation (July 2015), p 37
6 Ipsos Mori, Public attitudes to science 2014 (March 2014); University of Oxford (TSB0068), para 19
7 Centre for Process Innovation (TSB0020), para 3.2.1
8 Institution of Engineering and Technology (TSB0019)
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we must remember that we hold a position of great responsibility in the global scientific 
community. 
9. We face a century filled with complex societal challenges — ageing, chronic and 
complex illnesses, climate change, and sustainably feeding nine billion people. Our 
scientists and innovators across academia and industry will be at the forefront of the 
discoveries that will not only underpin the productivity of our economy but will ensure 
the sustainability of our way of life. 
10. We have a duty to take care that our spending and structural decisions in this area do 
more than merely maintain the status quo. If we get our spending priorities, our policies, 
regulatory frameworks or our immigration policy wrong, we will be on the wrong side of 
history.
Our inquiry
11. We decided to undertake an inquiry into the Science Budget, and to report ahead of 
the Spending Review. We began by taking oral evidence in July from Jo Johnson MP, the 
Minister for Universities and Science. We invited written submissions on the following 
issues:
• The extent to which the current ring-fence arrangements, and the separate arrangements 
for determining ‘resource’ and ‘capital’ allocations, have produced coherent UK science 
and research investment;
• The extent to which science and research expenditure in Government departments 
(outside the science budget) complements or competes with the science budget; 
• The need for and rationale for any adjustment to the trajectory of future Government 
expenditure on science and research, and what would be gained from an increase (or 
lost from a reduction) compared with current expenditure levels;
• Whether the current distributions of the budget between particular types of expenditure 
and between different organisations is appropriate for future requirements, and 
achieves an appropriate balance between pure and applied research;
• What level of Government expenditure on science and research is needed:
• to significantly drive the overall level of such expenditure in the economy, through 
synergies between government and private sector investment (including overseas 
investment); and
• to optimally balance its benefits against the opportunity cost of government 
expenditure foregone on other public services.
• Whether the Government’s expenditures on aspects of science and research are 
consistent with other government policies, including the Industrial Strategies and the 
Eight Great Technologies and fiscal incentive policies for research investment; and
• The extent to which any increase or reduction in Government expenditure on science 
and research will have an impact on the UK’s relative position among competitor 
states.
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12. We received 78 written submissions from a wide variety of sources: from academies 
to businesses, from charities to campaigners, from learned societies to individuals. We 
completed our oral evidence sessions, including a second meeting with the Minister, in 
October. We are grateful to all those who contributed evidence.
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2 What we spend on science and 
innovation now
The science budget
13. The science budget is managed by the Department for Business, Innovation and 
Skills (BIS). In May 2014, the Government published the 2015–16 resource and capital 
budget allocations for the science budget, with the largest beneficiaries being the research 
councils, the Higher Education Funding Council for England and the UK Space Agency. 
National academies like the Royal Society also benefit from this budget. In total, £4.7 
billion has been allocated for resource spending and £1.1 billion for capital.9
Resource
14. The ‘resource’ element of the budget has been broadly static in cash terms since 
2010–11. It remained unchanged in 2015–16 despite a post-General Election round of 
budget reductions for BIS itself. While protected from spending reductions that affected 
many departments in 2010, the effect of inflation means it will buy around 6% less in 
2015–16 than it did in 2010–11. The Campaign for Science and Engineering calculated 
that “the annual funding shortfalls resulting from the 2010 flat-cash settlement for the 
resource science budget have accumulated to a £1 billion loss to the UK research base over 
the lifetime of the last [2010–2015] Parliament.”10 
15. Most allocations within the total science budget have remained consistent over this 
period. Figure 1 shows the distribution of funding to the research councils and others in 
2015–16. The Higher Education Funding Council for England distributes the majority of 
its funds for research on the basis of research quality, and takes into account the volume 
and relative cost of research in different areas. This is called ‘quality-related research 
funding’.
Figure 1: Current science budget, 2015–16, £ million
9 The resource budget is slightly higher than the £4.6 billion ‘policy ring-fence’ agreed between BIS and HM Treasury 
This is because of additional funding for science in 2015–16 allocated at subsequent fiscal events. BIS thus makes a 
distinction between the science budget and the science ring-fence. (BIS (TSB0075), paras 41–43)
10 Campaign for Science and Engineering (TSB0051), para 9
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Capital
16. The corresponding capital science budget is smaller (Figure 2) and has fluctuated far 
more over the last few years, falling from £0.87 billion in 2010–11 to £0.42 billion in 2013–
14, before rising again to £0.86 billion in 2015–16 (Figure 3).  As is evident from Figure 3, 
the scale of the cut in the capital budget during the last Parliament created uncertainty for 
researchers and investors alike.
Figure 2: Capital science budget, 2015–16, £ million
Figure 3: Capital science budget, 2010–11 to 2015–16, £’000
Source: Science and technology budget allocations for financial year 2015–16, BIS, 2014
17. The Government’s manifesto commitment, repeated since the General Election, 
to inflation-protect the 2015–16 science capital budget of £1.1 billion up to 2021 is very 
welcome. It stands as a clear endorsement of the principle that long term stability in science 
funding is crucial to efforts not only to recruit and retain the best and brightest researchers 
but also essential for attracting large-scale inward investment. The Government stated 
that it would:
invest new capital on a record scale — £6.9 billion in the UK’s research 
infrastructure up to 2021 — which will mean new equipment, new laboratories 
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and new research institutes. This long-term commitment includes £2.9 billion 
for a Grand Challenges Fund, which will allow us to invest in major research 
facilities of national significance, such as the new Alan Turing Institute, and 
projects such as the Polar Research Ship and Square Kilometre Array.11
This reflects a trend in recent years of linking science investment funding commitments 
to specific projects or programmes.
18. The consequence of the Summer Budget’s target to run a surplus by 2019–20 is that 
all ‘unprotected’ departments, including BIS, must find savings of 25–40%. It should be 
noted, however, that in the overall scheme of Government spending, the science budget is 
modest, accounting for less than 1%. This means that a 10% increase, for example, would 
represent less than 0.1% of overall Government expenditure. 
Other science and innovation funding
19. There are many sources of public funding and support for the science and innovation 
ecosystem in addition to the ‘science budget’, presenting a complex support structure 
for researchers and innovators (Figure 4). These include innovation spending, R&D tax 
incentives and research in Government departments. As Figure 4 demonstrates, improving 
commercialisation is not simply about increasing funding. The complexity of the science 
and innovation landscape can act as a barrier to researchers and innovators seeking access 
to the support which is already available.
Figure 4: Academia/industry links (from Dowling report)
11 BIS (TSB0075), para 6
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Departmental research and development
20. Beyond the BIS science budget, several Government departments spend significant 
further sums on research and development, amounting in 2013 to some £4.17 billion, of 
which £1.52 billion is spent on defence research. Information on government research 
and development spending is summarised in Figure 5. R&D is distinguished from 
related activities by requiring an appreciable element of novelty and the resolution of 
scientific and/or technological uncertainty. This definition of R&D therefore excludes 
things like education, training, bibliographic and referencing work, routine technological 
development (e.g. the deployment of software systems that are already well understood) 
and the management of existing knowledge and data. 
Figure 5: 2013 R&D spending, £ million
21. Government departments’ spending on R&D, unlike the science budget, is not ring-
fenced. Departments can choose to increase or reduce it and reallocate resources as they 
see fit, depending on their priorities. Like other departments, BIS also spends on research 
and development in addition to the science budget.
Innovation
22. Government expenditure on innovation also lies outside the science budget, and 
consequently has not had ring-fence protection. It is also difficult to measure. It comprises 
funding for Innovate UK, but it can also encompass science-related research work in 
Government departments. Some 64% of UK R&D carried out between 1985 and 2013 
was performed by business, receiving funding from a variety of sources, including 
Government. 
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3 A roadmap for research and 
development
23. Even though “on many measures [the UK Science base] is the most efficient in the 
world”,12 producing excellent research in a highly competitive system, witnesses expressed 
near unanimous concern that at least since 2004 the UK’s level of public and private R&D 
investment has been internationally low and falling. Imperial College London were clear 
that this would have consequences:
the UK is falling behind its international competitors in terms of its investment 
in R&D. For example, in 2005 the UK invested 1.70% of GDP in R&D, increasing 
slightly to 1.82% in 2009 before declining back to 1.72% in 2012. In contrast, 
China increased its investment in R&D from 1.32% of GDP in 2005 to 1.98% in 
2012, and the US increased its investment in R&D from 2.51% of GDP in 2005 
to 2.79% in 2012. Within Europe, France increased its investment in R&D 
from 2.11% in 2005 to 2.26% in 2012, and Germany increased its investment 
in R&D from 2.51% in 2005 to 2.92% in 2012. Without increased investment 
in R&D, therefore, the UK risks losing its position at the forefront of research 
globally, particularly given the rapid rate of advance in scientific research and 
the intense levels of international competition.13
24. In 2013 gross domestic expenditure on R&D (GERD) in the UK was £28.9 billion. 
Between 1985 and 2013 GERD grew by 52% in real terms, but fell as a proportion of GDP 
from 2.01% to 1.67%.14 The UK government sector (research councils, higher education 
funding councils and Government departments) funded around 29% (£8.4 billion) of 
R&D performed in the UK in 201315 — less than 0.5% of GDP. OECD countries on average 
spend 2.4% of GDP on science, with in general about a third of this coming from public 
funds. The UK is placed 12th in the EU for total gross domestic expenditure on R&D 
(Figure 6).
12 Universities UK (TSB0045)
13 Imperial College London (TSB0013), para 1
14 House of Commons Library, Briefing Paper SN04223: Research and Development in the UK (July 2015)
15 Ibid. 
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Figure 6: Gross expenditure on R&D, 2013
25. The Campaign for Science and Engineering warned that although there are some 
statistical problems with GERD data, which is leading to underestimated UK GERD 
values and incomplete international league tables, the UK’s low international position for 
R&D investment could not be explained away as an anomaly and that our competitors are 
forging ahead, with some, like Israel and Korea, investing as much as 4.2%.16
Investment time lag
26. Along with many witnesses, the University of Oxford highlighted an investment time 
lag: “the effects of the recent downward trajectory in funding will not be seen for some 
time: Studies suggest that the average time from initial research to biomedical and health 
benefits is 15–20 years.”17 Universities UK similarly told us that: 
Research has shown that the time-lag between investment in science and 
the full realisation of benefits can be in the order of decades. As such, the 
consequences of failing to invest in a sustainable and effective research base 
now may not be immediately apparent; conversely, the positive outputs that we 
see now are the result of sound investments in the past, and efforts to create a 
sustainable research funding environment over the last decade.18
27.  The Minister went some way to acknowledging the time lag between research and its 
impacts when, in July, he told us: 
16 Campaign for Science and Engineering (TSB0051), para 66
17 University of Oxford (TSB0068), para 9
18 Universities UK (TSB0045)
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Of course, there is potential for these outputs to be lagging indicators, and 
we would want to be very wary of any slippage there. To the extent that the 
indicators continue to perform well we can be satisfied that we are investing 
at an appropriate level, but we would want to be very sensitive to the lagging 
factor. If that starts to emerge as a risk, we will be very attentive to it.19
28. The risk of such an approach, however, could be to hold back action until discrete 
areas of science actually manifest signs of deterioration. This same ‘lagging factor’ means 
that any remedy to such deterioration would not bear fruit for some years. This is clearly 
not a sensible way to manage a national strategic asset like our science and innovation 
ecosystem. Professor Alison Davenport, Chair of the advisory Science Board of the Science 
and Technology Facilities Council (STFC) told us that: 
The fact that we are currently still productive and “punch above our weight” 
despite five years of flat cash is at least in part due to the fact that we are living 
off investments from years/decades earlier. For example, both the discovery of 
the Higgs boson and the Rosetta mission are based on investments made in 
the 1990s.20 
STFC science and technology is in a precarious position.  We are living on 
past investments, and are currently on a knife-edge: flat cash for another five 
years will lead to an accelerated decline with serious and irreversible damage 
to particle physics, astrophysics and nuclear physics with loss of highly skilled 
staff, a trajectory for UK X-ray, neutron and laser facilities leading to closure of 
one facility and major loss of operations in the others, and serious damage to 
innovation and industrial engagement.21
Professor Brian Cox was just as alarmed:
If there is another flat cash settlement, realistically it is dire. That is not my 
opinion; it seems to be the unanimous opinion of the research councils. 
Certainly in my area, for the STFC, it is an absolute disaster. I would be 
extremely pessimistic if that happened.22
29. The Royal Society of Chemistry believed that even a real-terms freeze on science 
spending would leave the UK in danger of falling behind our competitors, many of whom 
are continuing to invest heavily in research and development. They wanted resource 
funding to be ring-fenced and protected against inflation, but also for the Government 
to “commit to a long-term ambition to increase science spending as economic growth 
returns”.23 Similarly, the Royal Society of Edinburgh wanted “to see the Government 
commit to at least a trajectory for the resource budget to be rising over the term of this 
Parliament and starting to close the investment gap with some of our key competitors”.24 
19 Q9
20 STFC’s Science Board (TSB0042), para 12
21 Ibid, para 31
22 Q212
23 Royal Society of Chemistry (TSB0035), para 8
24 Royal Society of Edinburgh (TSB0061), para 17
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The productivity case for R&D investment
30. In 2002, when the European Council adopted a target of spending 3% of GDP on 
public and private sector R&D, its economic analysis showed that the policy would “have 
a significant impact on long-term economic growth and employment in Europe, to the 
order of 0.5% of supplementary output and 400,000 jobs per year after 2010”.25
31. The Government’s own research shows that 51% of productivity growth between 2000 
and 2008 was due to innovation26 and that firms that consistently invest in R&D were 13% 
more productive than those that do not.27 The knowledge economy already accounts for 
one third of all jobs, with STEM jobs commanding salaries 20% above the average. 
32. There is also clear evidence that publicly funded R&D creates a strong ‘multiplier effect’ 
and ‘crowds-in’ private sector, charitable and inward investment, stimulating around 30% 
more self-investment from industry.28 For every £1 spent by the Government on R&D, 
private sector R&D productivity rises by 20p per year in perpetuity.29 As Universities UK 
told us: “this would imply … a total discounted value (at a 5% discount rate) of a 300% 
return on the initial investment. If the higher bound of the estimate is used, a discounted 
value of a 900% return on investment would be expected.”30 
Absorptive capacity
33. It is important to note the role of public sector R&D grants in promoting absorptive 
capacity in industry and why this matters for developing a competitive science and 
innovation ecosystem. Absorptive capacity is the “ability of a firm to identify, understand 
and exploit knowledge developed elsewhere in the innovation system”.31 Hughes and 
Martin argued in 2012 that: 
The impact of publicly funded research will be substantially affected by the 
capacity of other actors in the economic and innovation system to access, 
understand and use the research outputs produced with public sector support. 
This depends to a considerable extent on the R&D that the private sector itself 
carries out. R&D activity in the private sector has two purposes or ‘faces’; 
it creates new knowledge in itself but it also enhances the firm’s ‘absorptive 
capacity.’32 
34. It is no good having a fantastically productive research base if industry does not have 
enough people with the right set of skills to understand and develop those ideas. This is a 
crucial part of the innovation pipeline driven by R&D investment.
25 European Commission, Investing in research: An action plan for Europe (2003)
26 BIS, Our plan for growth: science and innovation – Evidence paper (December 2014), p5
27 Speech by Vince Cable,BIS Secretary of State, Innovation and the UK knowledge economy (July 2014)
28 Jonathan Haskel, Alan Hughes and Elif Bascavusoglu-Moreau, The Economic Significance of the UK Science Base 
(March 2014)
29 BIS, Estimating the effect of UK direct public support for innovation (Nov 2014)
30 Universities UK (TSB0045)
31 Hughes, A. Martin, B., Enhancing Impact: The Value of Public Sector R&D (2012)
32 Ibid
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Setting a roadmap for UK research and development investment
35. In 2014, the Business Innovation and Skills Committee recommended a target of 3% 
of GDP by 2020 for total R&D spending,33 while a report commissioned by the Government 
that year suggested 2.9% of GDP.34 Innovate UK cited two studies, the more conservative 
of which calculated that long run productivity is maximised with 2.3 – 2.6% of GDP spent 
on R&D.35 Crucially, they noted that, unlike our international peers, the UK does not 
have a long-term plan for increasing investment in R&D. The Royal Society favoured an 
increase in Government R&D expenditure to at least match the OECD average of 0.67% 
of GDP by 2020.  Naomi Weir of the Campaign for Science and Engineering called for 
R&D across Government to be increased by the end of this Parliament “above inflation, 
particularly with low inflation at the moment and the predictions for growth”.36 
36. The Government, however, does not seem to be convinced. Jo Johnson assured us 
that the productivity arguments for science investment were not lost on the Government: 
We are making a very strong case for the public and private returns on 
R&D expenditure. They are unarguable. There are private returns of 20% in 
perpetuity on every pound of public investment. We all agree on the evidence 
base around the crowding-in effect that public investment has on private 
investment … For every pound of public investment, between £1.13 and £1.59 
of private investment is crowded in. These are important factors, and the 
Treasury takes them into account.37
He nevertheless saw an EU target of spending 3% of GDP as “a nice round number, more 
than anything else”.38 He counselled against focusing on such targets and argued that 
research outputs were a more reasonable consideration than spending ‘inputs’.39 In other 
fields, where outcomes are more difficult to quantify, the Government is happy to commit 
to spending targets — legislating to set minimum spending on overseas development aid 
at the UN target (0.7% of national gross value added), and committing in the Summer 
Budget to meet NATO’s defence spending target of 2% of GDP.
37. The UK has fallen behind its competitors in terms of total R&D investment and 
this will put UK competitiveness, productivity and high-value jobs at risk if it is not 
reversed. We recommend that the Government produce a long term ‘roadmap’ for 
increasing public and private R&D investment in the UK to 3% of GDP. This would not 
only provide focus and accountability for public sector R&D investment but also send 
an important signal about the long term stability and sustainability of our science and 
innovation ecosystem, supercharging private sector R&D investment from UK industry, 
charities and overseas investors alike.
33 Business, Innovation and Skills Committee, Seventh Report of Session 2014–15, Business-University Collaboration, HC 
249.
34 BIS, Insights from international benchmarking of the UK science and innovation system (Jan 2014)
35 Innovate UK (TSB0048), para 39
36 Q150
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38 Q232
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4 Capital, resource and the ring-fence
38. While the Government has made a commitment to protect the £1.1bn annual capital 
science budget in real terms up to 2021, concerns have been raised on two points. Firstly, 
witnesses wanted assurances that this new budget commitment signalled not only much 
welcomed long term stability but also a greater degree of transparency and predictability 
for capital spending decisions. Secondly, witnesses almost unanimously called for better 
strategic linking between capital and resource allocations. 
39. The previous Government’s Science and Innovation Strategy (2014), which Jo Johnson 
MP described as “current ” in July,40 stated: 
Of course, capital investment alone is not sufficient to ensure our research 
infrastructure is able to continue to deliver world class outputs. We recognise 
that our science base requires adequate resource funding, and will give full 
consideration to these requirements when we take a decision at the Spending 
Review next year.41 
The failure to have adequate resource spending to match capital spending commitments, 
however, has been a recurrent theme throughout our inquiry. The STFC’s Science Board 
told us that:
under-exploitation of science infrastructure (failure to ‘sweat the assets’) as a 
result of inadequate resource for running costs is very wasteful and damaging 
to UK science. Of the UK’s X-ray, neutron and laser facilities, only Diamond 
(X-rays) is operating close to the optimum number of operations days.42 
The Royal Society of Chemistry gave the same example:
The £400m ISIS neutron source at Harwell currently operates well below 
maximum capacity and will run for only approximately 120 days this year, 
instead of an optimal 180 days, reportedly due to in insufficient funding for 
operational costs.43
40. In addition to high profile investment initiatives, capital funding is needed for core, 
enabling infrastructure. The University of Oxford told us that this remains in “critically 
short supply: whilst it lacks the ‘wow’ factor, investment in the routine, workhorse 
equipment that all institutions need to support excellent research and train the next 
generation of highly-skilled academic and industrial researchers is vital.” They added that: 
The requirement from research councils for institutions to contribute up to 
50% towards the cost of individual items of equipment (introduced in response 
to the cut in their capital budgets) and the low likelihood of securing industry 
co-funding for core infrastructure, presents further difficulties for the largest 
universities.44
40 Q2
41 HM Treasury and BIS, Our plan for growth: science and innovation, Cm 8980 (December 2014)
42 STFC’s Science Board (TSB0042), para 7
43 Royal Society of Chemistry (TSB0035), para 14
44 University of Oxford (TSB0068), para 6
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41. Resource and capital spending are to a great extent interdependent. Capital investment 
not accompanied by a supporting resource budget is likely to diminish the assets’ 
productive use. The phrase “batteries not included”, attributed to Lord Krebs,45 has been 
regularly cited as a major issue for capital investments.46 Innovate UK were particularly 
concerned about this point:
An effective innovation system links together ‘capital’ and ‘resources’ in an 
integrated package that supports and drives value creation…The ‘capital’ can 
be invested in a one to two year period to create the capability, but the ‘resource’ 
elements need to be in place for up to five years after the ‘capital’ to ensure the 
centre becomes established and sustainable.47 
42. While we welcome the Science and Innovation Strategy’s commitment to 
delivering sufficient resource funding, and the Minister’s assurance that this would 
be delivered, in reality, given existing capital commitments, this will only materialise 
with an upward trajectory in the resource budget. In addition, we are deeply concerned 
to hear of under-utilised facilities and a crisis in funding for mid-size equipment and 
core infrastructure. We recommend that the Government conduct an urgent review of 
all existing capital allocations to ensure sufficient resource is in place to fully ‘sweat 
our assets’ and further recommend development of a more robust system of integrating 
future capital and resource allocations so that full value is realised for every capital 
investment.
Accounting systems
43. Complicating the question of optimally balancing capital and resource budgets is the 
prospect of the distinction between them disappearing, at least in the public-sector R&D 
sphere. Professor Graeme Reid flagged up this issue in June 2015, noting that European 
Standard of Accounting 10 (‘ESA-10’) would require both resource and capital spending 
to be treated as capital investment in future.48 The logic behind this was a recognition 
by the Eurostat accounts-setters that even resource expenditure is designed “to increase 
the stock of knowledge”49 — an asset rather than consumption. Professor Reid told us 
in September that he expected the UK to introduce that protocol at some point after the 
Spending Review.50 Subsequently, Jo Johnson informed us that: 
For the Spending Review in November, my understanding is that they will 
observe the existing conventions of treating science resource and science 
capital as distinct pots of money. Thereafter, ESA-10 will start to apply, as it 
does in the [Office for National Statistics] national accounts, and there will be 
a new definition of resource spending as capital.51
44. The future treatment of capital and resource spending together could, if handled 
well, offer opportunities. Innovate UK believed that “a consistent approach that integrates 
45 Q194
46 Royal Society of Biology (TSB0084), para 1.2
47 Innovate UK (TSB0048), paras 13–14
48 Westminster Higher Education Forum, Priorities for science and innovation policy: opportunities, structures and 
investment (June 2015)
49 ONS, Transition to ESA 10: Impact on public sector finances (Feb 2014)
50 Q158
51 Q264
20  The science budget 
‘capital’ and ‘resource’ will build confidence and demonstrate that the UK is committed to 
the long-term creation of value.”52 The National Physical Laboratory envisaged that: 
More efficient use of overall science spending can be achieved by removing 
the separation between capital and programme budgets. Capital spend profiles 
at institutions with large scale facilities such as NPL would benefit from the 
ability to flex spending plans year on year, eliminating the practice of wasteful 
year-end spending from fixed, expiring budgets. Instead, providing funding 
at institution level would allow organisations to decide how best to apportion 
investment between new capabilities and resource, resulting in greater value 
for money.53 
45. Universities UK, on the other hand, cautioned against treating these two kinds of 
funding as equivalent, given their distinct objectives.54
46. The Spending Review is being conducted under present protocols, dealing with 
capital and resource budgets for science separately. Any subsequent change to the way 
in which science and innovation spending are classified must be transparent, allowing 
like-for-like comparisons with year-on-year expenditures set in the Spending Review. 
The Government should make it clear in the Spending Review that ESA-10 will not be 
used as a means to change the underlying funding settlement.
Ring-fence
47. Many of our witnesses highlighted the benefits of the ring-fencing mechanism, 
irrespective of the sums involved, in providing certainty and confidence to allow long-
term planning. Not only is this important for the direct beneficiaries of science funding, 
it matters to businesses attracted by our strong science base. Dr Paul Beasley of Siemens 
told us: 
Certainly for business, there is a need for some sort of stability. The introduction 
of the impact agenda and the industrial strategy five years ago was quite 
important for us to convince headquarters that there was strategic importance 
in any investments they made, and we could grow that. The possibility now 
that some of that would be reversed and that there is potential for a cut would 
call into question future investment in this particular area.55
Innovate UK pointed to the long history of the ring-fence as evidence of its effectiveness 
as a policy mechanism:
... the ring-fence has remained in place as responsibility for the science and 
research has moved from one government department to another over the 
last 25 years (during which time, government responsibility for science and 
research has been in the Department for Education and Science, the Cabinet 
Office, the Department of Trade and Industry, the Department of Innovation, 
Universities & Skills and the Department of Business, Innovation & Skills). 
Ring-fencing has provided confidence and stability for long-term science at 
52 Innovate UK (TSB0048), para 19
53 National Physical Laboratory (TSB0030), para 4.1
54 Universities UK (TSB0045)
55 Q321
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times of economic turbulence and organisational change. It has created an 
environment in which businesses and charities from around the world often 
choose to invest in long-term strategic relationships with the UK science base 
in preference to other countries.56 
48. If the case for a ring-fence of the science budget seems clear cut, however, the debate 
about what should fall within it is not. During the last Parliament, although the ring-
fence was protected, a number of different budgets moved in and out of the ring-fence. 
In addition, major strands of funding like the innovation budget and departmental 
R&D, accounting for billions of pounds of Government investment in our science and 
innovation ecosystem, sit not only outside the ring-fence but spread throughout different 
Government departments and budgets.
Innovation
49. Government expenditure on innovation has not had ring-fence protection. It is 
difficult to measure because it includes not only Innovate UK, but also some science-
related research work in Government departments (paragraph 20). 
50. Innovate UK’s budget doubled during the last Parliament. They highlighted, however, 
that “over recent years the BIS science budget has far outweighed the innovation budget”. 
The 2014–15 budget for the research councils was £2.7bn, for HEFCE £3.9bn and for 
Innovate UK £0.4bn. Innovate UK emphasised that businesses invest “significantly more 
in translation/development and commercialisation than on early stage research”, and they 
believed that their own budget was “disproportionately low”.57
51. Dr Ruth McKernon of Innovate UK and Martyn Sené of the National Physical 
Laboratory argued that innovation spending should be protected in similar ways to the 
science budget. Martyn Sené believed that “the infrastructures, such as the catapults 
and NPL, and the interventions, such as those made by Innovate UK, need long-term 
sustainable policy and funding behind them; otherwise, you have an F1 engine and no 
transmission.”58
52. Innovate UK suggested that the rationale for ring-fencing some budgets and not 
others needed to be revisited. They considered that funding for innovation through 
support of business and for infrastructure, such as through catapult centres, should be 
afforded ring-fence protection. Translation of early-stage research, through the stages of 
the ‘Technology Readiness Scale’, to deliver commercial products and businesses, they 
pointed out, is equally a long-term endeavour.59 Our predecessor Committee examined 
this ‘valley of death’ in 2013.60 
53. In July, the Minister told us: 
As a Government, we are committed to making sure that we exploit fully 
the commercial potential of the research and science base in which we are 
56 Innovate UK (TSB0048), para 10
57 Innovate UK (TSB0048)
58 Q87
59 Innovate UK (TSB0048), para
60 Science and Technology Committee, Eighth Report of Session 2012–13, Bridging the valley of death: improving the 
commercialisation of research, HC 348
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investing so heavily. The innovation budget plays a really important part in 
that. As you may recall, in our manifesto we commit to important elements 
of the innovation programme, including expanding our successful catapult 
network.61 
54. Numerous witnesses questioned how further catapults could be funded and if current 
catapult funding would be affected. Referring to two new catapults (precision medicine 
and medical technologies), Jo Johnson MP assured us that these “do not impact on the 
funding streams in the business cases for the catapults we already have.”62 However, in 
written evidence, Innovate UK described existing challenges facing some catapults:
Two of [Centre for Process Innovation’s] major centres are facing challenges 
within the current UK funding environment, where adequate ‘capital’ has 
been invested but the ‘resource’ support is inadequate for the UK to maximise 
its value creation. These projects are the National Biologics Manufacturing 
Centre and the National Formulation Centre. In both of these cases, the 
required ‘capital’ has been delivered but the ‘resources’ to run the centres have 
been made available for only one year, and are not adequate for the operating 
costs that are particularly pronounced in the early years of operation, as the 
facilities ramp up and industrial engagement progresses from zero to fully 
utilised. This obviously causes a number of problems to CPI, but it also has 
a major impact on the private sector partner networks that plan to use the 
centres. These partners include multinational companies, such as GSK or 
Proctor & Gamble, SMEs and university spin-outs. As a result, multi-nationals 
will redirect spending to other countries and the UK capability will be lost or 
never created — thus losing competitiveness. However, the negative impact 
is greater on the smaller companies as, in many cases, they do not have the 
financial strength to develop their processes and business models without 
the collaborative partnership that comes from working in the UK innovation 
system with the catapult centres.63 
55. The catapult network is a key success of the last Government’s commitment to 
strengthen our capacity to exploit research by building better research-industry 
partnerships. It is understandable, therefore, that the current Government should wish 
to build on this success by expanding the catapult network. While we commend the 
motivation, we feel the first priority should be to consolidate and establish the existing 
catapults — in particular ensuring that all catapults have the necessary operating 
resource and business strategies in order to operate at peak capacity.
56. Catapults are only one strand of innovation support, however, and commitments 
to expanding the catapult network should not come at the expense of other innovation 
priorities. The Government has made successive, clear commitments to innovation more 
generally and should deliver on these by ring-fencing Innovate UK’s budget.
61 Q5
62 Q7
63 Innovate UK (TSB0048), paras 16–17
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Departmental research and development
57. The Scienceogram campaign was among the contributors to our inquiry that 
highlighted the role of spending across Government: 
Just under half of UK public R&D funding is disbursed directly by Government 
departments. As well as contributing to the general advancement of knowledge 
across a range of socially and economically important areas, this research 
should underpin evidence-based policymaking across government.64 
The Royal Society of Edinburgh believed that overall science policy and the links with the 
science and research budgets of departments such as Health, DEFRA and the Ministry of 
Defence were not clear. They told us:
It is not completely transparent as to what proportion is spent on straightforward 
procurement of equipment and how much is supporting research. In addition, 
as the departmental budgets overall have been declining in recent years, it 
is likely that the individual spend on research within each department has 
declined. This makes it even more important that the Government starts to 
increase the science budget year on year.65 
The Academy of Social Sciences described research by Government departments as 
a “Bermuda Triangle”, with the expenditure discretionary and usually a very small 
proportion of departmental budgets.66 
58. We will soon begin an ‘evidence check’ exercise to test the degree to which policies are 
well-founded in scientific research. The exercise will over time, we hope, help departments 
to seek to fully utilise their departmental research resources and budgets. We recommend 
that major government policy announcements and new legislation should be routinely 
accompanied by a formal statement of the relevant evidence base, without depending 
on a prompt from our forthcoming evidence checks. 
59. The Royal Society of Edinburgh put a good case for more information, including an 
annual report, on Government science spending across all departments.67 It would enable 
the science and business communities, and Parliament, to better monitor and track the 
level of government support for innovation as well as science. 
60. We are dismayed by the steep decline in research and development in some 
departments. This is driven by understandable budgetary pressures but also by lack 
of transparency surrounding these budgets. We recommend that the Government 
produces an annual report to Parliament setting out, and explaining, public spending 
on science and innovation, including the rationale for the relative support given to 
scientific research and to innovation. 
64 Scienceogram UK (TSB0028), para 18
65 Royal Society of Edinburgh (TSB0061), para 26
66 Academy of Social Sciences (TSB0036)
67 Royal Society of Edinburgh (TSB0061), para 10
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5 Distribution
Dual support
61. The distribution of the science budget raises two issues: the proportion of funding 
that goes to HEFCE and how the remainder should be apportioned among individual 
research councils. In the lead up to the Spending Review, it has been reported that BIS’s 
work to identify financial savings, as a ‘non-protected’ department, might impinge on 
the way the science budget is allocated. McKinsey were commissioned by BIS to review 
operating costs across the Department and its ‘partner bodies’. Such partners include 
the Higher Education Funding Council for England and the research councils — the 
two organisations which allocate the bulk of the science budget to researchers under 
the so-called ‘dual support’ system. We received some assurances from the Secretary 
of State during our inquiry that McKinsey’s work had not addressed the science budget 
allocations. Concerns remained, however, that if the operating costs of the funding bodies 
are dramatically reduced, the efficacy of their funding allocation systems and the research 
they fund may be indirectly impacted.
62. The Higher Education Funding Council for England, which distributes the majority 
of its funds for research on the basis of research quality, takes into account the volume 
and relative cost of research in different areas ( ‘quality-related research funding’). 
David Sweeney of HEFCE pointed out that “over 90% of our highly-cited, world-
leading publications have university authorship, and we have universities in all parts of 
the country with diverse missions tackling global and local problems … It is not just 
research that is one of our jewels in this country; our universities are.”68 He attributed 
much of the success of the UK’s science base to the ‘dual support’ system.69 Universities 
UK believed that the system of dual support was “fundamental to the autonomy of higher 
education institutions”, in accordance with the Haldane Principle70 (an iteration of which 
was published by the previous Government in 2010).71 Universities lie at the heart of our 
success as a scientific nation, performing three-quarters of publicly funded R&D — a 
significantly higher proportion than in comparator countries.72 When it comes to making 
funding decisions for science, the central importance of the UK university sector must 
continue to remain uppermost in ministerial minds. 
63. The Institution of Engineering and Technology suggested, however, that the balance 
of HEFCE science block grant and research council funding should gradually be shifted 
more in favour of the latter. They considered that “HEFCE block grants should be limited 
to fewer universities and higher-impact research, rather than being spread thinly over a 
number of institutions.”73 
64. The ‘dual support’ system has produced a world class and highly efficient system 
for scientific research. Any significant changes to this system, including the balance 
of funding between research councils and university funding councils, would require 
a clear justification, which has yet to emerge. The Government should make clear its 
68 Q107
69 Q108
70 Universities UK (TSB0045)
71 HC Deb 20 December 2010, col 138WS
72 Universities UK (TSB0045)
73 Institution of Engineering and Technology (TSB0019), para 12
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continued commitment to the dual support system and the previous Government’s 2010 
iteration of the Haldane Principle in the forthcoming Spending Review. A significant 
element of research funding should continue to be channelled though both the research 
councils and the higher education funding authorities.  
Research councils
65. The President of the Royal Society, Sir Paul Nurse, is undertaking a review of the 
research councils, the results of which will be available for consideration in the Spending 
Review. He indicated to us that he saw scope for critically examining the way funding is 
allocated between the research councils and how their work is coordinated: 
It is interesting to note that the essential spending between the seven research 
councils remains rather stable over quite a few years. You have to wonder what 
that means, but it suggests that history may have quite a big impact on the 
future. That is certainly how some would interpret it. Personally, I think it 
might indicate that we need greater focus on overall strategic thinking and 
that maybe we do not have in our present structures the proper forum for 
those sorts of discussions to take place. It is not the easiest issue to deal with, 
because we need long-term stability but we also need agility.74 
66. Evidence from Universities UK showed that while allocations between research 
councils had remained static over the last decade, there had been a shift in the balance 
of research council investment between basic (or fundamental) research and applied 
research, from a ratio of 67%:32% to 62%:36%, between 2002 and 2013.75 Professor Rick 
Rylance of Research Councils UK acknowledged the role of history in determining 
funding allocations among research councils, but was worried that “if you start shifting 
too suddenly or too drastically, you will rob Peter to pay Paul and you run the risk of 
causing more damage than any possible good you can do. That may sound Panglossian, 
but it is a serious anxiety about perturbing the system.”76
67. In July, Jo Johnson MP told us that: 
It has always been the case that Governments have set strategic priorities and 
made allocations between disciplines—for example, in terms of how much 
money research councils individually receive—that reflect bigger societal 
considerations, and that will continue to be the case.77 
68. Given the stable nature of funding allocations between the various research 
councils and the drive for greater strategic oversight in science funding, it is in order 
to consider if the research councils are working as an optimal system. However, the 
shift towards applied research over the last decade and the efficient, competitive and 
innovative output of the science they fund, imply that research councils are continuing 
to reflect changing research priorities and driving excellence in our science base. 
74 Q65
75 Office for National Statistics, Government expenditure on Science, Engineering and Technology, 2013 (July 2015). The 
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69. While most witnesses accept there is scope for better interdisciplinary working 
and strategic oversight between research councils, clear justification will be needed 
for any significant change in funding allocations, beyond simply seeking further 
administrative efficiency savings or structural adjustments. Sir Paul Nurse’s review will 
guide this process, and the Government will no doubt weigh its conclusions carefully. 
But we caution against a radical reorganisation of the research councils which could 
potentially harm the research programme. 
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6 Research and industry
Private investment
70. Businesses spend more than government on research and development. In 2013, 
business enterprise was responsible for £18.4 billion (64%) of UK gross domestic 
expenditure on R&D. Charities are also a significant source of funding for science. Cancer 
Research UK were among a large number of contributors to our inquiry who pointed out 
that, by investing in science, the Government leverages investment from businesses and 
charities. For example, in 2013, medical research charities funded £1.3 billion of health 
research, a third of all publicly funded medical research.78 Many of our witnesses were 
acutely aware of the need to leverage as much funding as possible from the private sector. 
Dr Ruth McKernon of Innovate UK told us: 
I think it would help us, at a time when there is money in the private markets, 
to look at where there are opportunities to leverage additional private money. 
We already do matched funding, but is there a way we could get yet further 
funding from investment sources to help us grow those businesses and scale 
them? That is not an area we have focused on so far. We do really well with 
the funding we have. Both Innovate UK and the research councils are very 
efficient, but we are innovative; that is what we do, and we should not stop 
trying to make the money go as far as possible.79 
71. The excellence of the United Kingdom’s science base materially affects the level of 
inward investment by businesses, both in research and development and more generally.80 
There is a wide body of evidence that, in the context of the UK’s research sector, increases 
in public sector investment leverage increased private sector investment rather than 
crowd it out.81 Universities UK emphasised the importance of stable public expenditure: 
“A long-term commitment by government to maintain or increase support for research 
leverages substantial private research and development investment as it gives the private 
and charitable sector confidence to invest over a longer time horizon than they otherwise 
might.”82 The Royal Society of Chemistry believed that cutting public expenditure in 
research would be likely to trigger similar, additive, cuts from private investment.83
Mapping the science and innovation landscape
72. Among the key issues raised by Dame Ann Dowling in her recent review of business-
university collaborations are a need to reduce the complexity of current support systems 
and to provide clearer advice to businesses: “The over-arching recommendation” of her 
review was that 
Government should seek to reduce complexity wherever possible and, where 
simplification is not possible, every effort should be made to ensure that the 
interface to businesses and academics seeking support for collaborative R&D 
78 Cancer Research UK (TSB0005), para 12
79 Q86
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81 Universities UK (TSB0045)
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is as simple as possible, even if internally the system of schemes is complex: a 
process that has been referred to as ‘hiding the wiring’.84 
73. Efforts to identify the different players and opportunities in the innovation space 
would also make it simpler for entrepreneurs to find what funding opportunities exist 
that are most suited to their needs. Dr Ruth McKernon told us that much of Innovate 
UK’s work involved “asking how we can make it simpler for the person who wants to start 
a business and wants to know where to go to get funding, help and support to grow their 
company.”85 The “wiring” could be hidden without short circuiting the system. Innovate 
UK could have an important role as a guide to the opportunities available.86 Martyn 
Sené told us that the NPL, other national laboratories and the catapults were important 
assets “sitting in the space between academia and businesses”, and that “there need to be 
mechanisms and ways of getting our heads round where the capability is and how we can 
best use it.”87 
74. We are disappointed that the Government has yet to respond to the Dowling Report 
given its important insights into gaps in our innovation landscape. We recommend 
that the Government presents its response in the Spending Review.
Financing and fiscal incentives
75. Tax incentives — reliefs which reduce tax and effectively leave more funds available 
for spending — have become an increasingly significant policy instrument to boost the 
R&D activities of businesses. With claims for 2012–13 totalling £1.4bn, R&D tax credits are 
now the largest source of Government support for business investment in R&D.88 A recent 
study found that between £1.50 and £2.30 of additional R&D expenditure is stimulated by 
£1 of tax foregone.89 The Royal Society of Chemistry observed that support for innovation 
and innovative companies is an essential component of a healthy research ecosystem.90
76. Recent reports suggest that the Government is considering converting at least 
some innovation grants to industry into interest-bearing loans. Virginia Acha from the 
Association of the British Pharmaceutical Industry has been reported as stating that: 
This would have potentially devastating consequences for the whole life-
sciences sector, particularly the small to medium-sized biopharma enterprises. 
It takes on average 12 years and £1bn to develop a new medicine and, without 
support in the early stages to support SMEs in de-risking the process in a 
notoriously uncertain sector, innovation across life sciences would be seriously 
affected.91
Other sectors have echoed these concerns, stating that debt is not a viable financial 
option for funding early-stage, high-risk start-ups because it would raise their risk profile, 
84 The Dowling Review of Business-University Research Collaborations (July 2015)
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putting off potential investors. The strong multiplying effect of public R&D investment in 
crowding-in investment, and stimulating innovation, productivity and high value jobs, 
is based on its power to de-risk and bridge the ‘valley of death’. ‘Re-risking’ innovation 
funding by converting it into loans will reduce those benefits. In the meantime, competitor 
nations are dramatically increasing their direct R&D support to industry. The Institution 
of Engineering and Technology told us:
Competitive position in certain commercial markets has been achieved by 
large US companies often through 100% funded government research and 
development. This is most striking in aerospace where a number of technologies 
and sometimes whole engines in civil aerospace sector were derived from 
defence funded research.92 
77. Innovation loans may have a role to play as a new, additional, funding mechanism 
for later-stage ventures, but their success will depend greatly on the terms of any loans 
system introduced. We recommend that the Government retains the current system 
of innovation grants as a key policy tool, alongside R&D tax credits, for de-risking 
innovation investment.
78. If innovation funding was changed to loans, it would undermine the progress that 
the Government has made with tax incentives. Bernard Ross of Sky Medical Technology 
Limited described the “phenomenal environment with [the Enterprise Investment 
Scheme], R&D tax credits, grants and various other things that really are phenomenally 
supportive of innovation.”93 James Bromley of SwiftKey also talked approvingly of the 
Enterprise Investment Scheme, as well as the Seed Enterprise Investment Scheme: “I think 
the SEIS and EIS schemes have been absolutely brilliant for tech businesses, but there is 
one major issue: they have a lifetime cap” under EU state-aid rules. He concluded that “To 
commend what is being done with EIS and SEIS is correct, but there are some dark clouds 
looming for a number of companies who are reaching their lifetime limits.”94
79. A further example of an incentive for businesses to engage in research is the R&D tax 
credit scheme. According to the Minister, this is one of the most generous schemes in the 
OECD.95 James Bromley of SwiftKey echoed this but suggested improvements: “Typically, 
you may not get your R&D tax credit for 15 months after you first start incurring the cost, 
at best.” He suggested moving to a quarterly payment model, like that for VAT.96
80. Tax incentives have become a significant and welcome support for businesses 
seeking funding to innovate by applying research, but there remains scope for further 
assistance. Given the often thin operating margins of risky innovative start–ups, the 
delay in waiting for R&D tax credits is not ideal. We recommend that the Treasury 
critically examine in the Spending Review the potential for extending the scope and 
availability of tax incentives and investment vehicles for innovation businesses. It 
should also examine alternative models for R&D tax credit payment, including the 
scope for a quarterly schedule.
92 Institution of Engineering and Technology (TSB0019)
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Conclusions and recommendations
A roadmap for research and development
1. The UK has fallen behind its competitors in terms of total R&D investment 
and this will put UK competitiveness, productivity and high-value jobs at risk 
if it is not reversed. We recommend that the Government produce a long term 
‘roadmap’ for increasing public and private R&D investment in the UK to 3% of 
GDP. This would not only provide focus and accountability for public sector R&D 
investment but also send an important signal about the long term stability and 
sustainability of our science and innovation ecosystem, supercharging private 
sector R&D investment from UK industry, charities and overseas investors alike. 
(Paragraph 37)
Capital, resource and the ring-fence
2. While we welcome the Science and Innovation Strategy’s commitment to delivering 
sufficient resource funding [for science infrastructure], and the Minister’s assurance 
that this would be delivered, in reality, given existing capital commitments, this will 
only materialise with an upward trajectory in the resource budget. In addition, we 
are deeply concerned to hear of under-utilised facilities and a crisis in funding for 
mid-size equipment and core infrastructure. We recommend that the Government 
conduct an urgent review of all existing capital allocations to ensure sufficient resource 
is in place to fully ‘sweat our assets’ and further recommend development of a more 
robust system of integrating future capital and resource allocations so that full value 
is realised for every capital investment. (Paragraph 42)
3. The Spending Review is being conducted under present protocols, dealing with capital 
and resource budgets for science separately. Any subsequent change to the way in 
which science and innovation spending are classified must be transparent, allowing 
like-for-like comparisons with year-on-year expenditures set in the Spending Review. 
The Government should make it clear in the Spending Review that ESA-10 will not be 
used as a means to change the underlying funding settlement. (Paragraph 46)
4. The catapult network is a key success of the last Government’s commitment to 
strengthen our capacity to exploit research by building better research-industry 
partnerships. It is understandable, therefore, that the current Government should 
wish to build on this success by expanding the catapult network. While we commend 
the motivation, we feel the first priority should be to consolidate and establish the 
existing catapults — in particular ensuring that all catapults have the necessary 
operating resource and business strategies in order to operate at peak capacity. 
(Paragraph 55)
5. Catapults are only one strand of innovation support, however, and commitments to 
expanding the catapult network should not come at the expense of other innovation 
priorities. The Government has made successive, clear commitments to innovation 
more generally and should deliver on these by ring-fencing Innovate UK’s budget. 
(Paragraph 56)
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6. We recommend that major government policy announcements and new legislation 
should be routinely accompanied by a formal statement of the relevant evidence 
base, without depending on a prompt from our forthcoming evidence checks. 
(Paragraph 58)
7. We are dismayed by the steep decline in research and development in some 
departments. This is driven by understandable budgetary pressures but also by lack 
of transparency surrounding these budgets. We recommend that the Government 
produces an annual report to Parliament setting out, and explaining, public spending 
on science and innovation, including the rationale for the relative support given to 
scientific research and to innovation.  (Paragraph 60)
Distribution
8. The ‘dual support’ system has produced a world class and highly efficient system 
for scientific research. Any significant changes to this system, including the balance 
of funding between research councils and university funding councils, would require 
a clear justification, which has yet to emerge. The Government should make clear its 
continued commitment to the dual support system and the previous Government’s 
2010 iteration of the Haldane Principle in the forthcoming Spending Review. A 
significant element of research funding should continue to be channelled though both 
the research councils and the higher education funding authorities.   (Paragraph 64)
9. Given the stable nature of funding allocations between the various research councils 
and the drive for greater strategic oversight in science funding, it is in order to 
consider if the research councils are working as an optimal system. However, the 
shift towards applied research over the last decade and the efficient, competitive 
and innovative output of the science they fund, imply that research councils are 
continuing to reflect changing research priorities and driving excellence in our 
science base.  (Paragraph 68)
10. While most witnesses accept there is scope for better interdisciplinary working 
and strategic oversight between research councils, clear justification will be needed 
for any significant change in funding allocations, beyond simply seeking further 
administrative efficiency savings or structural adjustments. Sir Paul Nurse’s review 
will guide this process, and the Government will no doubt weigh its conclusions 
carefully. But we caution against a radical reorganisation of the research councils 
which could potentially harm the research programme. (Paragraph 69)
Research and industry
11. We are disappointed that the Government has yet to respond to the Dowling Report 
given its important insights into gaps in our innovation landscape. We recommend 
that the Government presents its response in the Spending Review. (Paragraph 74)
12. Innovation loans may have a role to play as a new, additional, funding mechanism 
for later-stage ventures, but their success will depend greatly on the terms of any 
loans system introduced. We recommend that the Government retains the current 
system of innovation grants as a key policy tool, alongside R&D tax credits, for de-
risking innovation investment. (Paragraph 77)
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13. Tax incentives have become a significant and welcome support for businesses 
seeking funding to innovate by applying research, but there remains scope for 
further assistance. Given the often thin operating margins of risky innovative 
start–ups, the delay in waiting for R&D tax credits is not ideal. We recommend that 
the Treasury critically examine in the Spending Review the potential for extending 
the scope and availability of tax incentives and investment vehicles for innovation 
businesses. It should also examine alternative models for R&D tax credit payment, 
including the scope for a quarterly schedule. (Paragraph 80)
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Formal Minutes
Tuesday 3 November 2015
Members present:
Nicola Blackwood, in the Chair
Chris Green
Dr Tania Mathias
Carol Monaghan
Graham Stringer
Derek Thomas
Matt Warman
Draft Report (The science budget), proposed by the Chair, brought up and read.
Ordered, That the draft Report be read a second time, paragraph by paragraph.
Paragraphs 1 to 80 read and agreed to.
Summary agreed to.
Resolved, That the Report be the First Report of the Committee to the House.
Ordered, That the Chair make the Report to the House.
Ordered, That embargoed copies of the Report be made available, in accordance with the 
provisions of Standing Order No. 134.
 [Adjourned till Tuesday 10 November at 2.00 pm
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The following witnesses gave evidence. Transcripts can be viewed on the Committee’s 
inquiry page at www.parliament.uk/science.
Wednesday 15 July 2015 Question number
Joseph Johnson MP, Minister of State for Universities and Science,  
Gareth Davies, Director General, Knowledge and Innovation, and  
Philippa Lloyd, Director General, People and Strategy, Department for 
Business, Innovation and Skills
Q1–47
Sir Paul Nurse, President, The Royal Society, Professor Richard Parker CBE 
FREng, Chair, Research and Secondments Committee, Royal Academy of 
Engineering, Lord Stern of Brentford, President, British Academy, and 
Professor Sir John Tooke, President, Academy of Medical Sciences
Q48–69
Tuesday 8 September 2015
Dr Ruth McKernan CBE, Chief Executive, Innovate UK, and Martyn Sené, 
Deputy Director and Operations Director, National Physical Laboratory
Q70–105
David Sweeney, Director (Research, Education and Knowledge Exchange), 
Higher Education Funding Council for England, Professor Rick Rylance, 
Executive Group Chair, Research Councils UK, and Professor Philip Nelson, 
Executive Group Chair-elect, Research Councils UK
Q106–140
Tuesday 15 September 2015
Professor Graeme Reid, Chair, Science and Research Policy, University 
College London, Naomi Weir, Acting Director, Campaign for Science and 
Engineering, and Nicola Dandridge, Chief Executive, Universities UK
Q141–174
Professor Sir Mark Walport, Government Chief Scientific Adviser, 
Government Office for Science
Q175–205
Professor Brian Cox, Physicist Q206–223
Tuesday 13 October 2015
Joseph Johnson MP, Minister of State for Universities and Science, and  
Gareth Davies, Director General, Knowledge and Innovation, Department 
for Business, Innovation and Skills
Q224–286
Bernard Ross, Chief Executive Officer, Sky Medical Technology Limited,  
James Bromley, Chief Operations Officer, SwiftKey, and Dr Paul Beasley, 
Head of Research and Development UK, Siemens
Q287–335
35 The science budget 
Published written evidence
The following written evidence was received and can be viewed on the Committee’s inquiry 
web page at www.parliament.uk/science. TSB numbers are generated by the evidence 
processing system and so may not be complete.
1 ABPI (TSB0058)
2 Academy of Medical Sciences (TSB0076)
3 Academy of Social Sciences (TSB0036)
4 ADS (TSB0026)
5 Alzheimer’s Research UK (TSB0069)
6 Arthritis Research UK (TSB0031)
7 Association of Medical Research Charities (TSB0041)
8 Association of Research Managers and Administrators (TSB0021) 
9 Babraham Institute (TSB0002)
10 BioIndustry Association (BIA) (TSB0060)
11 British Academy (TSB0052)
12 British Council (TSB0038)
13 British Heart Foundation (TSB0015) 
14 British Psychological Society (TSB0067)
15 British Society for Immunology (TSB0010)
16 Business, Innovation and Skills (TSB0075)
17 Campaign for Science and Engineering (TSB0051)
18 Cancer Research UK (TSB0005)
19 Celgene Ltd (TSB0040)
20 Centre for Process Innovation Limited (TSB0020)
21 Corewire Ltd (TSB0057)
22 Department for Business Innovation & Skills and the Department for Education 
(TSB0087)
23 Design Council (TSB0056)
24 Dr Peter Hedges (TSB0053)
25 EEF (TSB0074)
26 Element Six Ltd, Global Innovation Centre (TSB0003)
27 Energy Strategy Fellowship (TSB0073)
28 Engineering Professors’ Council (TSB0009)
29 Engineering the Future (TSB0066)
30 Food Standards Agency (TSB0022)
31 Gen3 Systems Limited (TSB0044)
32 Genome Analysis Centre (TSB0071)
33 GSK (TSB0054)
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34 Higher Education Funding Council for England (TSB0065)
35 Imperial College London (TSB0013)
36 Innovate UK (TSB0048), (TSB0085)
37 Institution of Environmental Sciences (TSB0072)
38 Institute of Food Research (TSB0043)
39 Institute of Physics (TSB0070)
40 Institution of Engineering and Technology (TSB0019)
41 John Innes Centre (TSB0001)
42 Met Office (TSB0083)
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44 Miss Tessa Burrington (TSB0080)
45 NatCen Social Research (TSB0039)
46 National Centre for Universities and Business (TSB0059)
47 National Institutes of Bioscience (TSB0027)
48 National Nuclear Laboratory (TSB0049)
49 National Physical Laboratory (TSB0030)
50 NDE Research Association (TSB0025)
51 Northern Health Science Alliance (TSB0014)
52 Parkinson’s UK (TSB0018)
53 Political Studies Association of the UK (TSB0023)
54 Precision Acoustics Ltd (TSB0008)
55 Prof Toby Bruce (TSB0034)
56 Professor Alison Davenport (TSB0042)
57 Renewableuk (TSB0037)
58 Rolls-Royce (TSB0077)
59 Royal Academy of Engineering (TSB0079)
60 Royal Astronomical Society (TSB0050)
61 Royal Botanic Gardens, Kew (TSB0086)
62 Royal Society (TSB0063)
63 Royal Society of Edinburgh (TSB0061)
64 Royal Society of Biology (TSB0084)
65 Royal Society of Chemistry (TSB0035)
66 Russell Group (TSB0078)
67 Science Museum Group (TSB0033)
68 Scienceogram (TSB0028)
69 Scientists for Global Responsibility (TSB0016)
70 Scientists for Labour (TSB0012)
71 UK Computing Research Committee (TSB0017)
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72 Universities UK (TSB0045), (TSB0082)
73 University Alliance (TSB0055)
74 University of Oxford (TSB0068)
75 University of Leeds (TSB0046)
76 Worshipful Company of Scientific Instrument Makers (TSB0081)
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